Everyone is waiting for the global pandemic corona virus vaccine. However, officials appearing before a parliamentary panel on Friday said the Covid-19 vaccine would not be ready before next year.
The Center’s Department of Science and Technology, Department of Biotechnology, Council of Scientific and Industrial Research (CSIR) and the Principal Scientific Advisor to the Government, prepared for the corona on behalf of the Center in front of the Parliamentary Standing Committee on Science and Technology, Environment and Climate Change. Presented. There are 7.93 lakh cases of corona infection in India while 21,604 people have died from it.
Covid-19 vaccine to come by early next year
According to sources, the panel has been told that the Covid-19 vaccine may be available as early as next year. The panel was chaired by senior Congress leader Jairam Ramesh who attended the meeting along with six other members. This was the first meeting of the panel after a nationwide lockdown on March 25. Panel chief Jairam Ramesh on Twitter urged Vice President Venkaiah Naidu to allow more meetings of the parliamentary panel.
ICMR accelerates vaccine trial process
ICMR has developed an indigenous vaccine in partnership with Bharat Biotech International Limited (BBIL). Dr. Balaran Bhargava, DG, ICMR has asked the leading researchers to complete the clinical trial of the corona virus vaccine as soon as possible so that the world’s first corona vaccine can be given by 15 August.
The country’s top medical body has selected 12 institutes including one from Odisha for clinical trials of the country’s first indigenous Covid-19 vaccine. Apart from Odisha, the institutes selected for clinical trials are Visakhapatnam, Rohtak (Haryana), New Delhi, Patna, Belgaum (Karnataka), Nagpur (Maharashtra), Gorakhpur, Kanpur (UP), Kattanulathur (Tamil Nadu), Hyderabad, Arya Nagar and Are located in Goa.
Scientists raise questions on ‘deadline of vaccine’
Many experts have feared that this may compromise the safety and reliability of ICMR. In addition, scientists have rejected the ICMR timeline to launch the vaccine until 15 August. At the same time, scientists have also questioned the feasibility of mass production of the vaccine if the desired results are achieved.
The ICMR defended its decision, stating that they are committed to making public safety a top priority and that the process of expediting the vaccine is in accordance with ‘globally accepted norms’.